Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor dna kinetics

HIGHLIGHTS

  • who: Jiawei Lv from the Department of Radiation Oncology, Sun Yat‑sen University Cancer of China have published the research: Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics, in the Journal: (JOURNAL)
  • what: The authors demonstrated and proposed that early on-treatment tumor responses, not only radiological response but also ctDNA-based biological responses, harbored critical prognostic information and that incorporating these factors greatly enhanced patient risk stratification. On this note, the authors propose that on-treatment cfEBV DNA kinetics provide critical information not . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?